FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Nipro Diagnostics, Inc., announced today that the U.S. Food and Drug Administration (FDA) has cleared its TRUE METRIX® AIR Self-Monitoring blood glucose system - a device for people with diabetes to test blood glucose and deliver data wirelessly to a smartphone.
As the diabetes store-brand leader and largest U.S. manufacturer of diabetes products for the store brand market, Nipro Diagnostics made the announcement to healthcare executives attending the National Association of Chain Drug Stores Annual Meeting in Palm Beach, Florida.
“Our new TRUE METRIX AIR Self-Monitoring blood glucose system is technology with reach,” said Scott Verner, CEO and President of Nipro Diagnostics. “Nipro Diagnostics’ customers have a better way to deliver superior health and wellness products that empower people with diabetes and their health support network to make better decisions for a healthier life,” continued Verner.
The innovation behind TRUE METRIX AIR delivers on Nipro Diagnostics’ commitment to elevate store brand product offerings that solve patient needs. TRUE METRIX AIR uses TRUE METRIX test strips featuring TRIPLE SENSE TECHNOLOGY™, which detects, analyzes and corrects for environmental and physiological variability - including hematocrit and temperature - with proven precision and accuracy.
The launch is a key element of Nipro Diagnostics’ strategic plan to create a model of interconnected patient health and wellness solutions that aids chronic disease management and increases patient engagement.
TRUE METRIX AIR adds to Nipro Diagnostics’ growing portfolio of high-performance, high-quality product solutions for people with diabetes. The company manufactures and distributes supplemental health and wellness products including sharps, neutraceuticals, personal care products, and dietary supplements and continues to expand its portfolio.
TRUE METRIX AIR will be available starting the second quarter of 2015 at a value price point through retail, mail and distribution channels under store brands and Nipro Diagnostics’ own TRUE brand of products.
ABOUT NIPRO DIAGNOSTICS, INC.
Nipro Diagnostics, Inc. is a global health and wellness company based in Fort Lauderdale, Florida and a leading developer, manufacturer and marketer of advanced performance products for people with diabetes. Sold under TRUE and store brand labels, the company is the exclusive partner and supplier of affordable, high-quality blood glucose monitoring and health and wellness solutions for the world’s leading retail pharmacies, distributors and mail service providers. For more information, please visit: www.niprodiagnostics.com.
04/2015 NICO-3527 Nipro Diagnostics, Inc. TRUE METRIX and TRIPLE SENSE TECHNOLOGY are trademarks of Nipro Diagnostics, Inc.
